New England Research & Management, Inc.

Position in INCY — Incyte Corp

CIK 1596077 CHICAGO, IL

Position in INCY

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$405,262

-$1,133,600 QoQ

Shares Held

3,575

-78.1% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#559

of 849 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

New England Research & Management, Inc. holds $4,649,048 across 5 Biotechnology names. INCY ranks #4 (8.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	3,475	$2,166,801
2	VRTX	Vertex Pharmaceuticals Inc / Ma	2,575	$1,279,079
3	MRNA	Moderna, Inc.	6,850	$479,705
4	INCY	Incyte Corp This page	3,575	$405,262
5	AXSM	Axsome Therapeutics, Inc.	1,300	$318,201

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$405,262	3,575	-78.1%	Shares	Sole	2026-07-09
2026-03-31	$1,538,862	16,350	-6.0%	Shares	Sole	2026-05-07
2025-12-31	$1,718,598	17,400	—	Shares	Sole	2026-01-07
No filing history on record for this holder in this stock.